Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Renal Impairment

Pharmacy : Journal of Pharmacy, Education and Practice
Soo Min JangHuyentran Tran

Abstract

Direct oral anticoagulants (DOACs) are gaining popularity for patients with nonvalvular atrial fibrillation (AF) for stroke prevention. Less bleeding risk with comparable stroke prevention compared to warfarin was shown. DOACs have predictable anticoagulant effects, infrequent monitoring requirements and less drug-food interactions compared to warfarin. However, safety and efficacy data of DOACs in patients with chronic kidney disease (CKD) are limited. This is a retrospective study to evaluate thromboembolic and bleeding events in patients with AF (with/without CKD) in October 2010 and July 2017. A total of 495 patients were included and only 150 patients had CKD. Our study found that patients with renal impairment on a DOAC do not have a higher incidence of bleeding events. It showed significant increase in thromboembolic events in CKD patients with dabigatran compared to CKD patients with apixaban with odds ratio of 6.58 (95%CI 1.35-32.02, p = 0.02).

References

May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Aug 13, 2011·The New England Journal of Medicine·Manesh R PatelUNKNOWN ROCKET AF Investigators
Aug 30, 2011·The New England Journal of Medicine·Christopher B GrangerUNKNOWN ARISTOTLE Committees and Investigators
Aug 17, 2012·The New England Journal of Medicine·Jonas Bjerring OlesenChristian Torp-Pedersen
Nov 21, 2013·The New England Journal of Medicine·Robert P GiuglianoUNKNOWN ENGAGE AF-TIMI 48 Investigators
Jan 27, 2017·Circulation·Emelia J BenjaminUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
May 10, 2017·The Annals of Pharmacotherapy·Stefanie C SarrattRobert Moye
May 30, 2017·Indian Journal of Nephrology·S Nayak-Rao, M P Shenoy
Aug 22, 2017·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·David Massicotte-AzarniouchManish M Sood
Mar 24, 2018·Current Opinion in Nephrology and Hypertension·Justin Ashley, Manish M Sood
May 29, 2018·Clinical Journal of the American Society of Nephrology : CJASN·Nishank Jain, Robert F Reilly
Jan 17, 2019·Clinics in Colon and Rectal Surgery·Audrey S KulaylatChristopher S Hollenbeak
Jan 30, 2019·Journal of the American Geriatrics Society·UNKNOWN By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel
Feb 23, 2019·Current Opinion in Nephrology and Hypertension·Jeffrey T HaMin Jun
May 19, 2019·Clinical Cardiology·Viviana Aursulesei, Irina Iuliana Costache

❮ Previous
Next ❯

Citations

Mar 4, 2021·Current Cardiology Reports·Evan M White, James C Coons
Apr 20, 2021·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Xiaole SuYipu Chen
Jun 12, 2021·Current Opinion in Pulmonary Medicine·Michelle C LamarchePhilip S Wells

❮ Previous
Next ❯

Software Mentioned

SPSS
ARISTOTLE
LY
RE

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.